SUNVAX MRNA THERAPEUTICS Trademark

Trademark Overview


On Friday, July 28, 2023, a trademark application was filed for SUNVAX MRNA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the SUNVAX MRNA THERAPEUTICS trademark a serial number of 98107092. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, July 16, 2024. This trademark is owned by SUNVAX MRNA THERAPEUTICS INC.. The SUNVAX MRNA THERAPEUTICS trademark is filed in the Chemical Products category with the following description:

Lipids used in the manufacture of cosmetics, beverages, food products and food supplements for industry and scientific use; Nucleotides for scientific and industrial research use in the nature of mRNA and lipid nanoparticle-mRNA; nanoparticles for industrial purposes and scientific use, namely, lipid nanoparticles for mRNA delivery
sunvax mrna therapeutics

General Information


Serial Number98107092
Word MarkSUNVAX MRNA THERAPEUTICS
Filing DateFriday, July 28, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, July 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 21, 2024

Trademark Statements


Description of MarkThe mark consists of an image of the sun in orange, bordered in yellow with a partially shaded blue helical strand superimposed on blue wings followed by the words "SUNVAX MRNA THERAPEUTICS" in blue. The color white represents background or transparency only and is not part of the mark.
Pseudo MarkSUN VAX MRNA THERAPEUTICS
Indication of Colors claimedThe color(s) blue, orange and yellow is/are claimed as a feature of the mark.
Goods and ServicesLipids used in the manufacture of cosmetics, beverages, food products and food supplements for industry and scientific use; Nucleotides for scientific and industrial research use in the nature of mRNA and lipid nanoparticle-mRNA; nanoparticles for industrial purposes and scientific use, namely, lipid nanoparticles for mRNA delivery
NOT AVAILABLE"MRNA THERAPEUTICS"

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, August 28, 2023
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSUNVAX MRNA THERAPEUTICS INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBeverly, MA 01915

Party NameSUNVAX MRNA THERAPEUTICS INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBeverly, MA 01915

Trademark Events


Event DateEvent Description
Tuesday, August 1, 2023NEW APPLICATION ENTERED
Monday, August 28, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 29, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, March 29, 2024ASSIGNED TO EXAMINER
Wednesday, April 10, 2024NON-FINAL ACTION WRITTEN
Wednesday, April 10, 2024NON-FINAL ACTION E-MAILED
Wednesday, April 10, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 15, 2024EXAMINERS AMENDMENT -WRITTEN
Monday, April 15, 2024EXAMINERS AMENDMENT E-MAILED
Monday, April 15, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, April 15, 2024EXAMINER'S AMENDMENT ENTERED
Monday, April 15, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 1, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 21, 2024PUBLISHED FOR OPPOSITION
Tuesday, May 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 16, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT